Phase 1-2 Study of MEDI4736 Alone or In Combination With ADXS11-001 In Recurrent/Persistent or Metastatic Cervical or HPV + Head & Neck Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date10/21/16 → 10/20/18

Funding

  • inVentiv Health Clinical: $26,438.00